Cargando…
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial
The CLARITY trial (Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease) is a two-arm, multi-centre, randomised controlled trial being run in India and Australia that investigates the effectiveness of angiotensin receptor blockers in addition to standard care compa...
Autores principales: | McGree, J. M., Hockham, C., Kotwal, S., Wilcox, A., Bassi, A., Pollock, C., Burrell, L. M., Snelling, T., Jha, V., Jardine, M., Jones, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044378/ https://www.ncbi.nlm.nih.gov/pubmed/35477480 http://dx.doi.org/10.1186/s13063-022-06167-2 |
Ejemplares similares
-
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial
por: Hockham, Carinna, et al.
Publicado: (2021) -
EvaLuation of Interventions for informed Consent for randomIsed controlled Trials (ELICIT): developing a core outcome set
por: Gillies, Katie, et al.
Publicado: (2015) -
EvaLuation of early CRRT and beta-blocker InTervention in patients with ECMO (ELITE) trial: study protocol for a 2 × 2 partial factorial randomized controlled trial
por: Wang, Xiaofang, et al.
Publicado: (2022) -
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
por: Jardine, Meg J, et al.
Publicado: (2022) -
Implementation of machine learning in the clinic: challenges and lessons in prospective deployment from the System for High Intensity EvaLuation During Radiation Therapy (SHIELD-RT) randomized controlled study
por: Hong, Julian C., et al.
Publicado: (2022)